Early switch to second‐line tyrosine kinase inhibitor in chronic myeloid leukemia patients failing to achieve early molecular response. Issue 10 (29th July 2017) - Klil‐Drori, Adi J.; Yin, Hui; Azoulay, Laurent; Harnois, Michaël; Gratton, Michel‐Olivier; Del Corpo, Alexa; Olney, Harold J.; Delage, Robert; Laneuville, Pierre; Mollica, Luigina; Busque, Lambert; Assouline, Sarit E.; et al.